Connect with us

Hi, what are you looking for?

Investing

AstraZeneca shares slumped nearly 10% on Thursday after the drugmaker said its nerve disease treatment Wainua failed to achieve the primary objective in a...

Investing

Investor Insight With a sharp focus on discovery and resource growth, NevGold presents a compelling investment opportunity as an undervalued gold and critical metals...